Cargando…
Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease
Sickle cell disease (SCD) is a genetically inherited condition caused by a point mutation in the beta globin gene. This results in the production of the abnormal hemoglobin, sickle hemoglobin (HbS). Hydroxycarbamide, is an antimetabolite/cytotoxic which works by inhibiting ribonucleotide reductase,...
Autores principales: | Wiles, NM, Howard, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754089/ https://www.ncbi.nlm.nih.gov/pubmed/19816573 |
Ejemplares similares
-
P1436: AGEING IMPACTS HYDROXYCARBAMIDE DOSING IN PATIENTS WITH SICKLE CELL DISEASE
por: Doss, Isabelle, et al.
Publicado: (2023) -
5612984 AUDIT OF TRUST COMPLIANCE WITH BSH GUIDELINES FOR UTILISATION OF HYDROXYCARBAMIDE IN PATIENTS WITH SICKLE CELL DISEASE
por: Barker, R., et al.
Publicado: (2023) -
Detrimental effects of sickle cell disease and hydroxycarbamide on
ovarian reserve but uncertain impact on fertility
por: Joseph, Laure, et al.
Publicado: (2023) -
Hydroxycarbamide‐related cutaneous ulcer complicated by osteomyelitis
por: England, James T., et al.
Publicado: (2021) -
P1419: A SINGLE CENTRE PERSPECTIVE ON PREGNANCY OUTCOMES AND SICKLE CELL COMPLICATIONS IN WOMEN ON HYDROXYCARBAMIDE PERI-CONCEPTION.
por: Gregori, Maria, et al.
Publicado: (2023)